Cambridge Investment Research Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124M Buy
486,640
+9,167
+2% +$2.14M 0.28% 59
2026
Q1
$117M Buy
477,473
+6,086
+1% +$1.42M 0.3% 51
2025
Q4
$97.6M Buy
471,387
+912
+0.2% +$180K 0.26% 65
2025
Q3
$87.2M Buy
470,475
+12,346
+3% +$2.12M 0.24% 71
2025
Q2
$70M Sell
458,129
-20,558
-4% -$3.16M 0.21% 82
2025
Q1
$79.4M Buy
478,687
+39,584
+9% +$6.19M 0.27% 61
2024
Q4
$63.5M Sell
439,103
-21,426
-5% -$3.32M 0.21% 81
2024
Q3
$74.6M Buy
460,529
+4,142
+0.9% +$660K 0.25% 65
2024
Q2
$66.7M Sell
456,387
-40,665
-8% -$6.05M 0.25% 73
2024
Q1
$78.6M Buy
497,052
+14,188
+3% +$2.26M 0.3% 54
2023
Q4
$75.7M Sell
482,864
-29,620
-6% -$4.54M 0.32% 51
2023
Q3
$79.8M Sell
512,484
-53,490
-9% -$8.83M 0.37% 47
2023
Q2
$93.7M Buy
565,974
+10,471
+2% +$1.69M 0.43% 36
2023
Q1
$86.1M Buy
555,503
+32,154
+6% +$5.19M 0.42% 37
2022
Q4
$92.5M Buy
523,349
+11,412
+2% +$1.97M 0.48% 31
2022
Q3
$83.6M Buy
511,937
+9,340
+2% +$1.58M 0.47% 32
2022
Q2
$89.2M Buy
502,597
+12,853
+3% +$2.29M 0.48% 33
2022
Q1
$86.8M Buy
489,744
+3,452
+0.7% +$587K 0.4% 38
2021
Q4
$83.2M Buy
486,292
+4,979
+1% +$815K 0.37% 47
2021
Q3
$77.7M Sell
481,313
-37,334
-7% -$6.37M 0.38% 45
2021
Q2
$85.4M Sell
518,647
-4,723
-0.9% -$782K 0.41% 40
2021
Q1
$86M Buy
523,370
+27,100
+5% +$4.39M 0.47% 33
2020
Q4
$78.1M Sell
496,270
-24,422
-5% -$3.6M 0.46% 32
2020
Q3
$77.5M Buy
520,692
+17,793
+4% +$2.63M 0.52% 26
2020
Q2
$70.7M Buy
502,899
+12,692
+3% +$1.85M 0.53% 27
2020
Q1
$64.3M Buy
490,207
+47,080
+11% +$6.68M 0.62% 22
2019
Q4
$64.6M Buy
443,127
+33,948
+8% +$4.6M 0.5% 28
2019
Q3
$52.9M Buy
409,179
+1,584
+0.4% +$209K 0.46% 31
2019
Q2
$56.8M Buy
407,595
+16,565
+4% +$2.29M 0.52% 29
2019
Q1
$54.7M Buy
391,030
+15,793
+4% +$2.12M 0.52% 28
2018
Q4
$48.4M Buy
375,237
+17,129
+5% +$2.39M 0.54% 28
2018
Q3
$49.5M Buy
358,108
+19,503
+6% +$2.59M 0.47% 31
2018
Q2
$41.1M Sell
338,605
-10,762
-3% -$1.34M 0.43% 37
2018
Q1
$44.8M Sell
349,367
-3,180
-0.9% -$430K 0.5% 27
2017
Q4
$49.3M Buy
352,547
+21,076
+6% +$2.94M 0.58% 25
2017
Q3
$43.1M Buy
331,471
+3,676
+1% +$487K 0.58% 26
2017
Q2
$43.4M Buy
327,795
+7,575
+2% +$966K 0.64% 23
2017
Q1
$39.9M Buy
320,220
+19,336
+6% +$2.31M 0.68% 22
2016
Q4
$34.7M Buy
300,884
+24,209
+9% +$2.8M 0.65% 23
2016
Q3
$32.7M Sell
276,675
-15,170
-5% -$1.84M 0.61% 27
2016
Q2
$35.4M Buy
291,845
+14,552
+5% +$1.65M 0.75% 20
2016
Q1
$30M Buy
277,293
+7,674
+3% +$794K 0.68% 25
2015
Q4
$27.7M Buy
269,619
+20,359
+8% +$2.05M 0.66% 22
2015
Q3
$23.3M Buy
249,260
+23,799
+11% +$2.3M 0.67% 26
2015
Q2
$22M Buy
225,461
+4,875
+2% +$488K 0.61% 30
2015
Q1
$22.2M Buy
220,586
+6,400
+3% +$651K 0.63% 27
2014
Q4
$22.4M Buy
214,186
+10,580
+5% +$1.11M 0.69% 26
2014
Q3
$21.7M Buy
203,606
+8,098
+4% +$840K 0.64% 27
2014
Q2
$20.5M Buy
195,508
+11,065
+6% +$1.12M 0.71% 24
2014
Q1
$18.1M Sell
184,443
-90,863
-33% -$8.42M 0.68% 28
2013
Q4
$25.2M Sell
275,306
-4,016
-1% -$370K 1.03% 15
2013
Q3
$24.2M Buy
279,322
+6,820
+3% +$612K 1.06% 11
2013
Q2
$23.4M Buy
+272,502
New +$23.1M 1.19% 11

Other funds holding JNJ

Cambridge Investment Research Advisors's JNJ Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, buying an estimated $2.14M and bringing the position to 486,640 shares worth $124M. The position accounts for 0.28% of the portfolio, ranked #59.

Cambridge Investment Research Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cambridge Investment Research Advisors held 486,640 shares of Johnson & Johnson worth $124M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 9,167 Johnson & Johnson shares in Q2 2026, an estimated $2.14M.
  • Johnson & Johnson made up 0.28% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #59 holding.
  • Cambridge Investment Research Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.